• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION SEPRAFILM; BARRIER, ABSORABLE, ADHESION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION SEPRAFILM; BARRIER, ABSORABLE, ADHESION Back to Search Results
Catalog Number 638005
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Post Operative Wound Infection (2446)
Event Date 11/16/2023
Event Type  Injury  
Manufacturer Narrative
Should additional relevant information become available, a supplemental report will be submitted.
 
Event Description
It was reported that a patient underwent an internal anal sphincterotomy and ileostomy in which seprafilm was used.The following day, bloody drainage was observed from the midline wound.The next day drainage was performed under ct guidance, and there was pale blood drainage, so a drain was placed.Antibiotics piperacillin and tazobactam were started, and a wound infection was diagnosed.A day later the fever subsided and eating resumed.Three days later, the fever (36 degrees c) and wound infection improved, and the drain was removed.The next day, a fever developed (38 degrees c) and a small amount of fluid was observed below the abdominal wall of the left lower abdomen within the small mesentery on the pelvic floor.The following day, drainage was performed, and a trough value revealed drug-induced liver damage and decreased renal function.The antibiotic was continued, and abscess drainage was performed under ct guidance.Six days later the patient recovered.According to the physician the cause of the issue was dirt mixed in from the umbilicus.No additional information is available.
 
Manufacturer Narrative
Additional information: h4, h6 and h10.H4: device manufacture date: 07 oct 2022.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.The device was not received for evaluation; therefore, a device analysis could not be completed.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SEPRAFILM
Type of Device
BARRIER, ABSORABLE, ADHESION
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
Manufacturer (Section G)
GENZYME CORPORATION
51 and 74-80 new york avenue
framingham MA 01701
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 60073
2242702068
MDR Report Key18330057
MDR Text Key330546864
Report Number1416980-2023-06544
Device Sequence Number1
Product Code MCN
UDI-Device Identifier05413765588211
UDI-Public(01)05413765588211
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P950034
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/01/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number638005
Device Lot NumberCBYSEP059
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/24/2023
Initial Date FDA Received12/14/2023
Supplement Dates Manufacturer Received01/31/2024
Supplement Dates FDA Received02/01/2024
Date Device Manufactured10/07/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
NI.
Patient Outcome(s) Required Intervention;
Patient Age55 YR
Patient SexMale
-
-